Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 4Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1Advanced Cancer 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × indibulin × Clear all
NCT00591136 2012-07-19

Phase I Study of Indibulin in Patients With Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
47 enrolled
Other solid neoplasm

Solid Tumors

NCT00591890 2012-07-19

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Alaunos Therapeutics

Phase 1 Completed
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡